2023-07-06 03:30:10
Color CT scan of the upper thorax showing a tumor in the lung. VOISIN / PHANIE VIA AFP
No fewer than 433,136 new cases of cancer are expected to be declared in France in 2023 – 57% in men and 43% in women. Since 1990, the figure has doubled for both men and women, all types of cancer considered. Compared to 2018, as the data are updated every five years, this amounts to an additional 51,000 cases. The incidence estimates (new cases) were produced by the French National Cancer Institute (INCa), Health agency Santé publique France (SPF), the French Cancer Registry Network (Francim) and the Lyon public hospitals (Hospices civils de Lyon). They were published in the weekly epidemiological bulletin (Weekly epidemiological bulletin – BEH) on July 4, the same day as the INCa report “Panorama des cancers en France (Panorama of cancers in France).”
In France, cancer remains the first cause of premature death in men and the second in women with a total of 157,400 deaths in 2018. These figures are “concerning,” according to the health authorities, and warrant a “call for action.” The increase can be explained, for 78% in men and 57% in women, by the growth and aging of the population. The remainder is due to lifestyle and environmental factors. The median age for diagnosis is 70 for men and 68 for women.
Discounting demographic effects, new cancer cases are projected to increase by 42,686 in women and 25,499 in men between 1990 and 2023. The most frequent cancers remain those of the breast, prostate, lung, colon and rectum.
For both sexes, melanoma of the skin, pancreatic cancer and kidney cancer increased between 1990 and 2023. “In men, trends are rather favorable for other types of cancer,” noted Dr Florence Molinié, President of the Francim network. In women, on the other hand, “trends are unfavorable for more types of cancer, and even more so for tobacco-related cancers such as lung and pancreatic cancer.”
The tumors with the best survival rates, around 90%, are prostate, cutaneous melanoma and breast, followed by colorectal and cervical cancer (63% each). In contrast, certain cancers have a poor prognosis, with a five-year survival rate of less than 30%: central nervous system, lung, liver pancreas.
Lung: The need for screening
Lung cancer is the second most common cancer in men, and the third most common cancer in women. Its incidence has skyrocketed: +5% annually since 1990, while it has fallen slightly in men. “In one or two years’ time, lung cancer will have overtaken breast cancer in terms of mortality among women,” said Sébastien Couraud, pulmonologist and oncologist at Hospices civils de Lyon. In 2018, 10,300 deaths were recorded for the former, and 12,100 for the latter. According to Couraud, “there is no reason to imagine that the number of female cases won’t catch up with that of men. For a long time, this was a very masculine disease; today, it’s a disease of both sexes.”
You have 75.84% of this article left to read. The rest is for subscribers only.
1688635634
#Cancer #incidence #doubled #France